The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2019

Filed:

Jun. 29, 2015
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Tao Jiang, Rancho Santa Fe, CA (US);

Emilia S. Olson, La Jolla, CA (US);

Michael Whitney, San Diego, CA (US);

Roger Tsien, La Jolla, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/00 (2006.01); A61M 36/14 (2006.01); C07K 7/08 (2006.01); A61K 41/00 (2006.01); A61K 49/00 (2006.01); A61K 49/08 (2006.01); A61K 49/14 (2006.01); A61K 51/08 (2006.01); C07K 14/47 (2006.01); C07K 14/00 (2006.01); A61K 47/65 (2017.01); A61K 47/64 (2017.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 7/08 (2013.01); A61K 41/0095 (2013.01); A61K 47/64 (2017.08); A61K 47/645 (2017.08); A61K 47/65 (2017.08); A61K 49/0032 (2013.01); A61K 49/0043 (2013.01); A61K 49/0056 (2013.01); A61K 49/085 (2013.01); A61K 49/14 (2013.01); A61K 49/146 (2013.01); A61K 51/088 (2013.01); C07K 14/00 (2013.01); C07K 14/4728 (2013.01); A61K 38/00 (2013.01);
Abstract

A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. X may be cleaved extracellularly or intracellularly. The molecules of the present invention may be linear, cyclic, branched, or have a mixed structure.


Find Patent Forward Citations

Loading…